Inhibitors of prostaglandin transport and metabolism augment protease-activated receptor-2-mediated increases in prostaglandin E2 levels and smooth muscle relaxation in mouse isolated trachea.
Stimulants of protease-activated receptor-2 (PAR(2)), such as Ser-Leu-Ile-Gly-Arg-Leu-NH(2) (SLIGRL), cause airway smooth muscle relaxation via the release of the bronchodilatory prostanoid prostaglandin E(2) (PGE(2)). The principal aim of the current study was to determine whether compounds that inhibit PGE(2) reuptake by the prostaglandin transporter [bromocresol green and U46619 (9,11-dideoxy-9alpha,11alpha-methanoepoxy PGF2alpha) and PGE(2) metabolism by 15-hydroxyprostaglandin dehydrogenase (thiazolidenedione compounds rosiglitazone and ciglitazone) significantly enhanced the capacity of SLIGRL to elevate PGE(2) levels and produce relaxation in isolated segments of upper and lower mouse trachea. SLIGRL produced concentration-dependent increases in PGE(2) levels and smooth muscle relaxation, although both effects were significantly greater in lower tracheal segments than in upper tracheal segments. SLIGRL-induced increases in PGE(2) levels were significantly enhanced in the presence of ciglitazone and rosiglitazone, and these effects were not inhibited by GW9662 (2-chloro-5-nitrobenzanilide), a peroxisome proliferator-activated receptor-gamma antagonist. SLI-GRL-induced relaxation responses were also significantly enhanced by ciglitazone and rosiglitazone, whereas responses to isoprenaline, a PGE(2)-independent smooth muscle relaxant, were unaltered. Ciglitazone and rosiglitazone alone produced concentration-dependent increases in PGE(2) levels and smooth muscle relaxation, and these responses were inhibited by indomethacin, a cyclooxygenase inhibitor. Bromocresol green, an inhibitor of prostaglandin transport, significantly enhanced SLIGRL-induced increases in PGE(2) levels and relaxation. Immunohistochemical staining for 15-hydroxyprostaglandin dehydrogenase was relatively intense over airway smooth muscle, as was staining for the prostaglandin transporter over both airway smooth muscle and epithelium. In summary, inhibitors of PGE(2) reuptake and metabolism significantly potentiate PAR(2)-mediated increases in PGE(2) levels and smooth muscle relaxation in murine-isolated airways.
Henry
Peter J
PJ
School of Medicine and Pharmacology, University of Western Australia, Nedlands. phenry@receptor.pharm.uwa.edu.au
D'Aprile
Angela
A
Self
Glenn
G
Hong
Tracy
T
Mann
Tracy S
TS
D000818:Animals; D017920:Antiporters / Q000037:antagonists & inhibitors*; D001961:Bromcresol Green / Q000494:pharmacology; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors*; D015232:Dinoprostone / Q000032:analysis / Q000378:metabolism*; D005260:Female; D006911:Hydroxyprostaglandin Dehydrogenases / Q000032:analysis; D007150:Immunohistochemistry; D051379:Mice; D008807:Mice, Inbred BALB C; D009126:Muscle Relaxation / Q000187:drug effects*; D009842:Oligopeptides / Q000494:pharmacology; D027361:Organic Anion Transporters; D047495:PPAR gamma / Q000502:physiology; D044464:Receptor, PAR-2 / Q000502:physiology*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology; D014132:Trachea / Q000737:chemistry / Q000502:physiology*
D017920:Antiporters; D004268:DNA-Binding Proteins; D009842:Oligopeptides; D027361:Organic Anion Transporters; D047495:PPAR gamma; D044464:Receptor, PAR-2; C503527:Slco2a1 protein, mouse; D045162:Thiazolidinediones; C099570:seryl-leucyl-isoleucyl-glycyl-arginyl-leucine; D000077154:Rosiglitazone; D001961:Bromcresol Green; D006911:Hydroxyprostaglandin Dehydrogenases; C035859:15-hydroxyprostaglandin dehydrogenase; D015232:Dinoprostone; C039671:ciglitazone